Varenicline for vaping cessation emerges as a promising solution for teens and young adults struggling with nicotine addiction.A recent study published by Mass General Brigham reveals that this FDA-approved nicotine treatment has the potential to greatly enhance quitting success rates among this vulnerable demographic.